Abstract
Pulmonary embolism (PE) is a common form of venous thromboembolism, which causes around 300,000-600,000 deaths every year in the US. Currently, there are a variety of methods to treat pulmonary embolism, including pharmacological, procedural, and surgical interventions. With the emergence of novel technology, physicians are able to utilize techniques such as catheter-directed thrombolysis (CDT) and ultrasound-accelerated thrombolysis (USAT) to treat PE. While literature exists on the safety and efficacy of CDT and USAT, little research has been published on the cost-effectiveness of the two interventions.
Full Text
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call